Data / Form D filings / Oyster Point Pharma, Inc.
Oyster Point Pharma, Inc.: Form D filings
Oyster Point Pharma, Inc., a pharmaceuticals company in Princeton, NJ, filed 2 Form D notices with the SEC between 2017 and 2019. The latest, on February 27, 2019, reports $85 million sold of a $93 million offering to 7 investors.
Find out what Oyster Point Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 700 ALEXANDER PARK DRIVE, SUITE 301, Princeton, NJ, 08540
- Phone
- (609) 382-9032
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1720725
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2019 | New notice | $92,999,999 | $84,999,985 | $8,000,014 | 7 | Feb 15, 2019 | sec.gov |
| Oct 25, 2017 | New notice | $43,125,784 | $28,614,800 | $14,510,984 | 8 | Oct 11, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William J Link | Director | |
| D. Michael Ackermann | Director | |
| Clare A. Ozawa | Director | |
| Benjamin A. Tsai | Director | |
| Ali J Behbahani | Director | |
| Jeffrey A. Nau | Executive Officer, Director | |
| Mark A. Murray | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Feb 25, 2019 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Oyster Point Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.